Role of Body Fat Distribution and the Metabolic Complications of Obesity
2008/11/01 by Michael D. Jensen · 28 citations
Medicine · #Liver Disease Diagnosis and Treatment #Diabetes, Cardiovascular Risks, and Lipoproteins #Cardiovascular Disease and Adiposity
paper · pdf · doi:10.1210/jc.2008-1585
Abstract
CONTEXT: An upper body/visceral fat distribution in obesity is closely linked with metabolic complications, whereas increased lower body fat is independently predictive of reduced cardiovascular risk. EVIDENCE ACQUISITION: The measured functions of different fat depots with regards to fatty acid storage and release in health and obesity were reviewed. The adverse effects of experimentally increasing free fatty acid (FFA) concentrations on liver, muscle, pancreatic beta-cell, and endothelial function were noted. EVIDENCE SYNTHESIS: The most dramatic abnormality in FFA metabolism is failure to suppress FFA concentrations/adipose tissue lipolysis normally in response to postprandial hyperinsulinemia. Upper body sc fat delivers the majority of FFA to the systemic circulation under postabsorptive and postprandial conditions. In upper body obesity, portal FFA concentrations resulting from both systemic and visceral adipose tissue lipolysis may be significantly greater than arterial FFA concentrations, exposing the liver to even greater amounts of FFA. Visceral fat also releases sufficient IL-6 to increase portal vein IL-6 concentrations, which can affect hepatic metabolism as well. CONCLUSIONS: Lower body, upper body sc, and visceral fat depots have unique characteristics with regards to fatty acid metabolism. Selective dysregulation of these depots probably plays an important role with the metabolic complications of obesity.
Citations
Cited by
- Pathophysiology of Human Visceral Obesity: An Update
- Adipokine dysregulation and adipose tissue inflammation in human obesity
- Estrogen: A master regulator of bioenergetic systems in the brain and body
- Fructose consumption: recent results and their potential implications. [europepmc]
- Transcriptional control of adipose lipid handling by IRF4. [europepmc]
- Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. [europepmc]
- Key questions and answers about pregnancy-associated plasma protein-A. [europepmc]
- Fat depots, free fatty acids, and dyslipidemia. [europepmc]
- Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. [europepmc]
- Estrogen: a master regulator of bioenergetic systems in the brain and body. [europepmc]
- Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? [europepmc]
- Shaping fat distribution: New insights into the molecular determinants of depot- and sex-dependent adipose biology. [europepmc]
- The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis. [europepmc]
- Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. [europepmc]
- Neck Circumference May Be a Better Alternative to Standard Anthropometric Measures. [europepmc]
- Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues. [europepmc]
- Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. [europepmc]
- Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. [europepmc]
- The Science of Obesity Management: An Endocrine Society Scientific Statement. [europepmc]
- NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development. [europepmc]
- Biomaterials to Mimic and Heal Connective Tissues. [europepmc]
- The Complex Interactions Between Obesity, Metabolism and the Brain. [europepmc]
- What lipodystrophies teach us about the metabolic syndrome. [europepmc]
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. [europepmc]
- Maternal Obesity and Diabetes Mellitus as Risk Factors for Congenital Heart Disease in the Offspring. [europepmc]
- Epigenetic Transgenerational Inheritance of Obesity Susceptibility. [europepmc]
- Mechanisms and disease consequences of nonalcoholic fatty liver disease. [europepmc]
- Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management. [europepmc]
Related